CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 67 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $102,364 | -87.3% | 17,528 | -85.4% | 0.00% | – |
| Q3 2022 | $806,000 | +34.8% | 120,260 | -15.4% | 0.00% | – |
| Q2 2022 | $598,000 | +896.7% | 142,096 | +694.3% | 0.00% | – |
| Q1 2022 | $60,000 | +7.1% | 17,890 | +1.4% | 0.00% | – |
| Q4 2021 | $56,000 | -3.4% | 17,640 | 0.0% | 0.00% | – |
| Q3 2021 | $58,000 | -21.6% | 17,640 | 0.0% | 0.00% | – |
| Q2 2021 | $74,000 | -86.2% | 17,640 | -83.5% | 0.00% | – |
| Q1 2021 | $535,000 | -57.5% | 107,189 | +7.7% | 0.00% | – |
| Q4 2020 | $1,258,000 | +25.2% | 99,487 | -2.8% | 0.00% | – |
| Q3 2020 | $1,005,000 | -1.9% | 102,375 | -0.5% | 0.00% | – |
| Q2 2020 | $1,024,000 | +14.8% | 102,897 | +2.0% | 0.00% | – |
| Q1 2020 | $892,000 | +14.5% | 100,858 | +19.4% | 0.00% | – |
| Q4 2019 | $779,000 | +58.7% | 84,442 | +1.1% | 0.00% | – |
| Q3 2019 | $491,000 | -55.5% | 83,495 | -9.2% | 0.00% | – |
| Q2 2019 | $1,104,000 | -13.9% | 91,976 | -13.5% | 0.00% | – |
| Q1 2019 | $1,282,000 | -1.9% | 106,279 | +2.0% | 0.00% | – |
| Q4 2018 | $1,307,000 | -51.3% | 104,196 | -42.4% | 0.00% | -100.0% |
| Q3 2018 | $2,682,000 | -6.7% | 180,780 | +5.8% | 0.00% | 0.0% |
| Q2 2018 | $2,876,000 | -20.4% | 170,848 | +8.4% | 0.00% | 0.0% |
| Q1 2018 | $3,611,000 | -29.6% | 157,644 | -20.5% | 0.00% | 0.0% |
| Q4 2017 | $5,127,000 | +172.1% | 198,192 | +55.2% | 0.00% | 0.0% |
| Q3 2017 | $1,884,000 | +7.2% | 127,724 | +1.4% | 0.00% | – |
| Q2 2017 | $1,757,000 | -17.0% | 125,996 | +1.5% | 0.00% | -100.0% |
| Q1 2017 | $2,118,000 | +72.5% | 124,144 | +4.1% | 0.00% | – |
| Q4 2016 | $1,228,000 | +9.1% | 119,271 | +7.1% | 0.00% | – |
| Q3 2016 | $1,126,000 | -20.0% | 111,411 | -11.1% | 0.00% | – |
| Q2 2016 | $1,407,000 | -16.0% | 125,269 | +2.2% | 0.00% | -100.0% |
| Q1 2016 | $1,675,000 | -30.6% | 122,608 | -3.6% | 0.00% | 0.0% |
| Q4 2015 | $2,412,000 | -45.1% | 127,183 | -45.7% | 0.00% | 0.0% |
| Q3 2015 | $4,396,000 | +16.5% | 234,205 | -7.6% | 0.00% | 0.0% |
| Q2 2015 | $3,774,000 | +88.8% | 253,486 | +92.1% | 0.00% | 0.0% |
| Q1 2015 | $1,999,000 | +11.4% | 131,981 | -2.0% | 0.00% | – |
| Q4 2014 | $1,794,000 | -17.7% | 134,646 | -22.1% | 0.00% | -100.0% |
| Q3 2014 | $2,180,000 | +50.8% | 172,882 | +20.8% | 0.00% | – |
| Q2 2014 | $1,446,000 | +563.3% | 143,064 | +782.2% | 0.00% | – |
| Q1 2014 | $218,000 | – | 16,216 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 2,610 | $620,000,000 | 6.47% |
| Parkman Healthcare Partners LLC | 1,124,072 | $4,732,000 | 1.74% |
| Kynam Capital Management, LP | 1,000,000 | $4,210,000 | 1.08% |
| EAM Investors, LLC | 850,647 | $3,581,000 | 0.87% |
| BVF INC/IL | 3,629,000 | $15,278,000 | 0.74% |
| EAM Global Investors LLC | 388,730 | $1,637,000 | 0.40% |
| RA Capital Management | 3,307,203 | $13,923,000 | 0.37% |
| Nantahala Capital Management | 1,659,840 | $6,988,000 | 0.35% |
| AWM Investment Company, Inc. | 504,661 | $2,125,000 | 0.34% |
| INGALLS & SNYDER LLC | 1,411,153 | $5,941,000 | 0.31% |